A Study in Non-Small Cell Lung Cancer

NCT01232452 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Carcinoma

Interventions

DRUG: Pemetrexed
DRUG: Cisplatin
DRUG: Cixutumumab

Sponsor

Eli Lilly and Company